BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36706708)

  • 21. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway.
    Bhat FA; Sharmila G; Balakrishnan S; Arunkumar R; Elumalai P; Suganya S; Raja Singh P; Srinivasan N; Arunakaran J
    J Nutr Biochem; 2014 Nov; 25(11):1132-1139. PubMed ID: 25150162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short low concentration cisplatin treatment leads to an epithelial mesenchymal transition-like response in DU145 prostate cancer cells.
    Liu YQ; Zhang GA; Zhang BC; Wang Y; Liu Z; Jiao YL; Liu N; Zhao YR
    Asian Pac J Cancer Prev; 2015; 16(3):1025-8. PubMed ID: 25735324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
    Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
    Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion.
    Nolan KD; Franco OE; Hance MW; Hayward SW; Isaacs JS
    J Biol Chem; 2015 Mar; 290(13):8271-82. PubMed ID: 25670862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13.
    Chen L; Hu W; Li G; Guo Y; Wan Z; Yu J
    Cell Mol Biol Lett; 2019; 24():20. PubMed ID: 30899277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
    Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
    Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.
    Liu X; Sun Z; Deng J; Liu J; Ma K; Si Y; Zhang T; Feng T; Liu Y; Tan Y
    Int J Oncol; 2018 Sep; 53(3):1279-1288. PubMed ID: 29956727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strontium ranelate affects signaling from mechanically-stimulated osteocytes towards osteoclasts and osteoblasts.
    Bakker AD; Zandieh-Doulabi B; Klein-Nulend J
    Bone; 2013 Mar; 53(1):112-9. PubMed ID: 23234812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanical Stimulation Modulates Osteocyte Regulation of Cancer Cell Phenotype.
    Verbruggen SW; Thompson CL; Duffy MP; Lunetto S; Nolan J; Pearce OMT; Jacobs CR; Knight MM
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity.
    Ito Y; Ishiguro H; Kobayashi N; Hasumi H; Watanabe M; Yao M; Uemura H
    Prostate; 2015 Jul; 75(10):1009-19. PubMed ID: 25917126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells.
    Huo C; Kao YH; Chuu CP
    Cancer Lett; 2015 Dec; 369(1):103-11. PubMed ID: 26297988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
    Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
    Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.
    Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET
    Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells.
    Zhang L; Sha J; Yang G; Huang X; Bo J; Huang Y
    Cell Cycle; 2017 May; 16(10):999-1007. PubMed ID: 28388267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Osteomimetic Response of Androgen-Dependent and Independent Human Prostate Cancer Cells to Mechanical Action of Fluid Flow: Prometastatic Implications.
    González Á; García de Durango C; Alonso V; Bravo B; Rodríguez de Gortázar A; Wells A; Forteza J; Vidal-Vanaclocha F
    Prostate; 2017 Feb; 77(3):321-333. PubMed ID: 27813116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.